Insider Selling: Dyne Therapeutics (NASDAQ:DYN) CFO Sells 1,448 Shares of Stock
MarketBeat
Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Free Report) CFO Erick Lucera sold 1,448 shares of the business's stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $18.36, for a total transaction of $26,585.28. Following the transaction, the chief financial officer directly owned 123,925 shares in the company, valued at $2,275,263. The trade was a 1.15% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
NASDAQ:DYN
